Breast Lesion Localization Methods Market

Breast Lesion Localization Methods Market By Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2025

Report Code: MD 4236 Jul, 2020, by marketsandmarkets.com

[157 Pages Report] Market for breast lesion localization methods is expected to grow from 3,974.4 thousands of procedures in 2020 to 5750.9 thousands of procedures by 2025, at a CAGR of 7.5% during the forecast period. The growth of this market is primarily driven by factors such as the rising incidence of breast cancer, an increasing number of breast cancer surgeries, and growing awareness on the early detection of breast cancer.

However, the uncertain regulatory approval process faced by prominent players is hampering the growth of the breast lesion localization methods market.

Breast Lesion Localization Methods Market

Covid-19 Impact on the Breast Lesion Localization Methods Market

The breast lesion localization methods market is not expected to be impacted greatly by the Covid-19 pandemic in 2020-2021. However, routine breast cancer screening at hospitals and annual screening programs have been suspended in many countries in order to maintain social distancing protocols and minimize patient flow in health care centers. Moreover, non-essential procedures and surgeries have been postponed for the post lockdown period which could have a slight impact on the market only for Q1 and Q2 of 2020 in most regions. breast lesion localization methods market.

Breast lesion localization methods Market Dynamics

DRIVER: GROWING INCIDENCE OF BREAST CANCER

Globally, there has been a significant growth in the number of breast cancer cases. This can majorly be attributed to changing lifestyles, increasing use of oral contraceptives, and the growing number of women undergoing cosmetic surgeries, such as breast enhancement. Following are some major statistics in this regard: In the US, one in eight women develop invasive breast cancer over the course of their lifetime. According to the American Cancer Society and the National Cancer Institute, in 2018, over 265,000 new cases of invasive breast cancer were diagnosed among women in the US. The growing incidence of breast cancer is resulting in a growth in the number of breast cancer surgeries. This, in turn, is driving the demand for the pre-operative localization of non-palpable breast cancer.

RESTRAINT: UNCERTAINTY IN REGULATORY APPROVAL PROCEDURES

Breast localization devices are Class II and III medical devices, and have to undergo a stringent regulatory procedure in order to be approved by the FDA. In the US, it takes around 3 to 7 years to prove the medical safety of any new device. As per law, even a new size of a previously approved device needs to go through the entire process before commercialization. With increasing technological advancements and growing focus on patient care, regulatory requirements are becoming more stringent and rigorous, requiring extensive data and documentation for the validation and approval of new technologies. The approval process is very lengthy and capital-intensive, which makes it difficult for small manufacturers and companies with limited budgets to sustain in this market.

Opportunity: EMERGING ECONOMIES OFFER HIGH GROWTH POTENTIAL

Governments in emerging countries are also investing heavily in the development and modernization of healthcare infrastructure. For instance, healthcare expenditure in China increased in 2016, as fiscal spending on healthcare grew by 10% year-on-year. Moreover, the incidence of breast cancer in these developing nations is also increasing exponentially. Given the opportunities presented by these emerging markets, key players are focusing on expanding their presence in the Asia Pacific region.

Challenge: SHORTAGE OF ONCOLOGISTS

Over the years, the incidence of breast cancer has increased significantly, and is expected to increase further in the coming years. However, there has not been a subsequent growth in the number of oncologists, and this situation is more pronounced in developing countries. This dearth of trained professionals is expected to hamper the growth of the breast lesion localization methods market during the forecast period.

Global Breast Lesion Localization Methods Market Interconnections

Breast Lesion Localization Methods Market

Wire localization accounted for the largest share in the market in the forecast period.

The wire localization segment accounted for the highest share of the procedures market, by type. The large share of this segment is attributed to its accuracy in abnormal tissue localization, minimal removal of normal tissues, minimal scarring, and availability of reimbursement for breast lesion localization devices. The ease of use of wire localization technology and the familiarity of end users with the technology have resulted in its increased adoption.

Sentinel lymph node identification expected to show the highest growth rate in the forecast period.

On the basis of usage, the breast lesion localization methods market is segmented into tumor identification and sentinel lymph node identification. The sentinel lymph node identification segment is expected to grow at the fastest rate in the forecast period, Growth in this segment can be attributed to the increase in acceptance of SLNB as a first-line diagnostic approach for breast cancer staging, as it is more sensitive and causes less morbidity than traditional techniques for the early staging of breast cancer.

The Asia Pacific region holds the largest share in the market during the forecast period of 2020–2025.

Geographically, the breast lesion localization methods market is segmented into North America, Europe, the Asia Pacific and Rest of the World. The large share of the Asia Pacific region is due to improving healthcare infrastructure, high government spending on breast cancer research, and rising awareness about the importance of the early detection of breast cancer in several APAC countries. Moreover, increasing focus of prominent players on emerging Asian countries will further support the growth of the market in this region.

Breast Lesion Localization Methods Market

Key Market Players

The key players operating in the breast lesion localization methods market include Becton, Dickinson and Company (US), Endomagnetics Limited (UK), SOMATEX Medical Technologies GmbH (Germany), Cianna Medical (US), Leica Biosystems (US) and IZI Medical Products (US).

Scope of the Report

Report Metric

Details

Market size available for years

2017–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD Million)

Segments covered

Product and Distribution Channel

Geographies covered

  • Asia Pacific
  • Europe
  • North America
    • US
    • Canada
  • Rest of the World

Companies covered

Hologic Inc. (US), Laurane Medical (US), Health Beacons, Inc (Australia), Mermaid Medical A/S (Denmark), IZI Medical Products (US), Matek Medical Inc. (Turkey), Tsunami Medical Inc. (Italy), BPB Medica (Italy), Sirius Medical BV (Netherlands), Molli Surgical Inc. (Canada), Argon Medical Devices (US), B.D. Company (US), Cianna Medical (US), Endomagnetics Ltd. (UK), Health Beacons, Inc. (Australia), Intra-Medical Imaging LLC (US), IsoAid, LLC (US), Leica Biosystems (Germany), SOMATEX Medical Technologies GmbH (Germany), SurgicEye GmbH (Germany) and Ranfac Corporation (US).

The research report categorizes the Breast Lesion Localization Methods market into the following segments and subsegments:

Breast Lesion Localization Methods Market, By Type

  • Wire Localization
  • Radioisotope localization
  • Magnetic localization
  • Electromagnetic localization
  • Other localization methods

Breast Lesion Localization Methods Market, By Usage

  • Tumor identification
  • Sentinel lymph node identification
  • Lumpectomy
  • Mastectomy

Breast Lesion Localization Methods Market, By Region

  • Asia Pacific
  • Europe
  • North America
    • US
    • Canada
  • Rest of the World

Recent Developments:

  • In 2019, Hologic Inc. (US) launched LOCalizer wire-free guidance system.
  • In 2019, Argon Medical Devices (US) acquired Mana-Tech, Ltd. (UK) enabling Argon to distribute its products across UK and Ireland.
  • In 2019, IZI Medical Products, LLC acquired Cook’s acquired product portfolio of soft tissue biopsy and breast localization needle assets to enable it to capture newer markets.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 26)
    1.1 Objectives Of The Study
    1.2 Market Definition
           1.2.1 Category-Wise Inclusions And Exclusions In The Breast Lesion Localization Market
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered For The Study
    1.4 Currency
Table 1 Standard Currency Conversion Rate
    1.5 Limitations
    1.6 Stakeholders
    1.7 Summary Of Changes

2 Research Methodology (Page No. - 30)
    2.1 Research Data
Figure 1 Research Design
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
Figure 2 Primary Sources For The Breast Lesion Localization Methods Market
                    2.1.2.1 Key Data From Primary Sources
Figure 3 Breakdown Of Primaries: Global Breast Lesion Localization Methods Market
    2.2 Market Size Estimation
           2.2.1 Market Sizing Approach For The Breast Lesion Localization Methods Market: Demand-Side Approach (Approach 1)
Figure 4 Market Size Estimation: Demand-Side Approach (Approach 1)
           2.2.2 Market Sizing Approach For The Breast Lesion Localization Methods Market: Demand-Side (Approach 2)
Figure 5 Market Size Estimation: Demand-Side Approach (Approach 2)
Figure 6 Market Size Estimation: Demand-Side Approach (Approach 3)
    2.3 Market Breakdown And Data Triangulation
Figure 7 Data Triangulation Methodology
           2.3.1 Assumptions

3 Executive Summary (Page No. - 41)
Figure 8 Breast Lesion Localization Methods Market, By Type,2020 Vs. 2025 (Thousand Procedures)
Figure 9 Radioisotope Localization Methods Market, By Type,2020 Vs. 2025 (Thousand Procedures)
Figure 10 Breast Lesion Localization Methods Market, By Usage,2020 Vs. 2025 (Thousand Procedures)
Figure 11 Geographic Snapshot: Breast Lesion Localization Methods Market

4 Premium Insights (Page No. - 45)
    4.1 Breast Lesion Localization Methods Market Overview
Figure 12 Rising Awareness Is Expected To Drive Market Growth
    4.2 Asia Pacific: Breast Lesion Localization Methods Market, 2019
Figure 13 Wire Localization Held The Largest Share Of The Asia Pacific Breast Lesion Localization Methods Market In 2019
    4.3 Breast Lesion Localization Methods Market: Geographic Mix
Figure 14 Asia Pacific Will Continue To Dominate The Breast Lesion Localization Methods Market Till 2025

5 Market Overview (Page No. - 48)
    5.1 Introduction
    5.2 Market Dynamics
Figure 15 Breast Lesion Localization Methods Market: Drivers, Restraints, Opportunities, And Challenges
    5.3 Drivers
           5.3.1 Growing Incidence Of Breast Cancer
Table 2 Top 10 Countries With The Highest Incidence Of Breast Cancer, 2018
Figure 16 Incidence Of Breast Cancer (Million Cases) From 2012–2025
           5.3.2 Increasing Number Of Breast Cancer Surgeries
Figure 17 Estimated Number Of Breast Cancer Surgeries (Million Cases) From 2012–2024
           5.3.3 Increasing Awareness On The Early Detection Of Breast Cancer
    5.4 Restraints
           5.4.1 Uncertainty In Regulatory Approval Procedures
    5.5 Opportunities
           5.5.1 Emerging Economies Offer High Growth Potential
           5.5.2 Increasing Adoption Of Technologically Advanced Localization Procedures
    5.6 Challenges
           5.6.1 Shortage Of Oncologists
    5.7 Impact Of Covid-19 On The Breast Lesion Localization Market: Restructuring Of Breast Cancer Care
    5.8 Adjacent Market Tables

6 Industry Insights (Page No. - 55)
    6.1 Industry Trends
           6.1.1 Electromagnetic Waves For Localization Of Breast Lesions
           6.1.2 Radiofrequency Identification In Breast Lesion Localization
           6.1.3 Machine Learning Algorithms For Computer-Aided Breast Lesion Detection
           6.1.4 Reimbursement Guidelines For Breast Lesion Localization Device Placement
Figure 18 Codes, Definitions, & Physician Payment For Breast Lesion Localization Procedures (Medicare & Medicaid Services - Hopps)
Figure 19 Reimbursement For Breast Lesion Localization Device Placement, 2014–2018

7 Breast Lesion Localization Methods Market, By Type (Page No. - 58)
    7.1 Introduction
Table 3 Breast Lesion Localization Methods Market, By Type,2017–2019 (Thousand Procedures)
Table 4 Breast Lesion Localization Methods Market, By Type,2020–2025 (Thousand Procedures)
Table 5 Breast Lesion Localization Methods Market, By Type,2017–2019 (USD Million)
Table 6 Breast Lesion Localization Methods Market, By Type,2020–2025 (USD Million)
    7.2 Wire Localization
Table 7 Wire Localization Methods Market, By Region,  2017–2019 (Thousand Procedures)
Table 8 Wire Localization Methods Market, By Region,2020–2025 (Thousand Procedures)
    7.3 Radioisotope Localization
Table 9 Radioisotope Localization Methods Market, By Type, 2017–2019 (Thousand Procedures)
Table 10 Radioisotope Localization Methods Market, By Type,2020–2025 (Thousand Procedures)
Table 11 Radioisotope Localization Methods Market, By Type, 2017–2019 (USD Million)
Table 12 Radioisotope Localization Methods Market, By Type, 2020–2025 (USD Million)
Table 13 Radioisotope Localization Methods Market, By Region, 2017–2019 (Thousand Procedures)
Table 14 Radioisotope Localization Methods Market, By Region,2020–2025 (Thousand Procedures)
Table 15 Radioisotope Localization Methods Market, By Region,2017–2019 (USD Million)
Table 16 Radioisotope Localization Methods Market, By Region,2020–2025 (USD Million)
           7.3.1 Radioguided Occult Lesion Localization (Roll)
Table 17 Radioguided Occult Lesion Localization Market, By Region, 2017–2019 (Thousand Procedures)
Table 18 Radioguided Occult Lesion Localization Market, By Region,2020–2025 (Thousand Procedures)
Table 19 Radioguided Occult Lesion Localization Market, By Region,2017–2019 (USD Million)
Table 20 Radioguided Occult Lesion Localization Market, By Region,2020–2025 (USD Million)
           7.3.2 Radioactive Seed Localization (Rsl)
Table 21 Radioactive Seed Localization Market, By Region,2017–2019 (Thousand Procedures)
Table 22 Radioactive Seed Localization Market, By Region,2020–2025 (Thousand Procedures)
Table 23 Radioactive Seed Localization Market, By Region,2017–2019 (USD Million)
Table 24 Radioactive Seed Localization Market, By Region,2020–2025 (USD Million)
    7.4 Magnetic Localization
Table 25 Magnetic Localization Methods Market, By Region,2017–2019 (Thousand Procedures)
Table 26 Magnetic Localization Methods Market, By Region, 2020–2025 (Thousand Procedures
Table 27 Magnetic Localization Methods Market, By Region,2017–2019 (USD Million)
Table 28 Magnetic Localization Methods Market, By Region, 2020–2025 (USD Million)
    7.5 Electromagnetic Localization
    7.6 Other Localization Methods
Table 29 Other Localization Methods Market, By Region,2017–2019 (Thousand Procedures)
Table 30 Other Localization Methods Market, By Region,2020–2025 (Thousand Procedures)
Table 31 Other Localization Methods Market, By Region,2017–2019 (USD Million)
Table 32 Other Localization Methods Market, By Region, 2020–2025 (USD Million)
    7.7 Covid-19 Impact On The Breast Lesion Localization Methods Market, By Type

8 Breast Lesion Localization Market, By Usage (Page No. - 72)
    8.1 Introduction
Table 33 Breast Lesion Localization Methods Market, By Usage,2017–2019 (Thousand Procedures)
Table 34 Breast Lesion Localization Methods Market, By Usage,2020–2025 (Thousand Procedures)
    8.2 Sentinel Lymph Node Identification
Table 35 Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Region, 2017–2019 (Thousand Procedures)
Table 36 Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Region, 2020–2025 (Thousand Procedures)
Table 37 North America: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Country, 2017–2019 (Thousand Procedures)
Table 38 North America: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Country, 2020–2025 (Thousand Procedures)
Table 39 Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type, 2017–2019 (Thousand Procedures)
Table 40 Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type, 2020–2025 (Thousand Procedures)
           8.2.1 Lumpectomy
                    8.2.1.1 High Survival Rates Favor The Adoption Of Lumpectomy
Table 41 Sentinel Lymph Node Identification Market For Lumpectomy,By Region, 2017–2019 (Thousand Procedures)
Table 42 Sentinel Lymph Node Identification Market For Lumpectomy,By Region, 2020–2025 (Thousand Procedures)
Table 43 North America: Sentinel Lymph Node Identification Market For Lumpectomy, By Country, 2017–2019 (Thousand Procedures)
Table 44 North America: Sentinel Lymph Node Identification Market For Lumpectomy, By Country, 2020–2025 (Thousand Procedures)
           8.2.2 Mastectomy
                    8.2.2.1 There Is A Low Risk Of Cancer Recurrence In Mastectomy
Table 45 Global Number Of Mastectomy Procedures Per 10,000 Population, 2012–2024
Table 46 Sentinel Lymph Node Identification Market For Mastectomy,By Region, 2017–2019 (Thousand Procedures)
Table 47 Sentinel Lymph Node Identification Market For Mastectomy,By Region, 2020–2025 (Thousand Procedures)
Table 48 North America: Sentinel Lymph Node Identification Market For Mastectomy, By Country, 2017–2019 (Thousand Procedures)
Table 49 North America: Sentinel Lymph Node Identification Market For Mastectomy, By Country, 2020–2025 (Thousand Procedures)
    8.3 Tumor Identification
           8.3.1 Increasing Focus On Early Breast Cancer Detection Driving The Growth Of The Tumor Identification Segment
Table 50 Breast Lesion Localization Methods Market For Tumor Identification, By Region, 2017–2019 (Thousand Procedures)
Table 51 Breast Lesion Localization Methods Market For Tumor Identification, By Region, 2020–2025 (Thousand Procedures)
Table 52 North America: Breast Lesion Localization Methods Market For Tumor Identification, By Country, 2017–2019 (Thousand Procedures)
Table 53 North America: Breast Lesion Localization Methods Market For Tumor Identification, By Country, 2020–2025 (Thousand Procedures)

9 Breast Lesion Localization Methods Market, By Region (Page No. - 81)
    9.1 Introduction
Table 54 Breast Lesion Localization Methods Market, By Region, 2017–2019 (Thousand Procedures)
Table 55 Breast Lesion Localization Methods Market, By Region,2020–2025 (Thousand Procedures)
    9.2 Asia Pacific
Figure 20 Asia Pacific Region: Breast Lesion Localization Methods Market Snapshot
           9.2.1 Covid-19 Impact On The Breast Lesion Localization Methods Market In The Asia Pacific
Table 56 Asia Pacific: Breast Lesion Localization Methods Market, By Type, 2017–2019 (Thousand Procedures)
Table 57 Asia Pacific: Breast Lesion Localization Methods Market, By Type, 2020–2025 (Thousand Procedures)
Table 58 Asia Pacific: Radioisotope Localization Methods Market, By Type, 2017–2019 (Thousand Procedures)
Table 59 Asia Pacific: Radioisotope Localization Methods Market, By Type, 2020–2025 (Thousand Procedures)
Table 60 Asia Pacific: Breast Lesion Localization Methods Market, By Usage, 2017–2019 (Thousand Procedures)
Table 61 Asia Pacific: Breast Lesion Localization Methods Market, By Usage, 2020–2025 (Thousand Procedures)
Table 62 Asia Pacific: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type,2017–2019 (Thousand Procedures)
Table 63 Asia Pacific: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type,2020–2025 (Thousand Procedures)
Table 64 Asia Pacific: Breast Lesion Localization Methods Market, By Type, 2017–2019 (USD Million)
Table 65 Asia Pacific: Breast Lesion Localization Methods Market, By Type, 2020–2025 (USD Million)
    9.3 Europe
           9.3.1 Covid-19 Impact On The Breast Lesion Localization Methods Market In Europe
           9.3.2 Germany
           9.3.3 France
           9.3.4 Uk
           9.3.5 Rest Of Europe
Figure 21 Europe: Breast Lesion Localization Methods Market Snapshot
Table 66 Europe: Breast Lesion Localization Methods Market, By Type, 2017–2019 (Thousand Procedures)
Table 67 Europe: Breast Lesion Localization Methods Market, By Type, 2020–2025 (Thousand Procedures)
Table 68 Europe: Radioisotope Localization Methods Market, By Type,2017–2019 (Thousand Procedures)
Table 69 Europe: Radioisotope Localization Methods Market, By Type,2020–2025 (Thousand Procedures)
Table 70 Europe: Breast Lesion Localization Methods Market, By Usage, 2017–2019 (Thousand Procedures)
Table 71 Europe: Breast Lesion Localization Methods Market, By Usage, 2020–2025 (Thousand Procedures)
Table 72 Europe: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type, 2017–2019 (Thousand Procedures)
Table 73 Europe: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type, 2020–2025 (Thousand Procedures)
Table 74 Europe: Breast Lesion Localization Methods Market, By Type, 2017–2019 (USD Million)
Table 75 Europe: Breast Lesion Localization Methods Market, By Type, 2020–2025 (USD Million)
    9.4 North America
           9.4.1 Covid-19 Impact On The Breast Lesion Localization Methods Market In North America
Figure 22 North America: Breast Lesion Localization Methods Market Snapshot
Table 76 North America: Breast Lesion Localization Methods Market,By Country, 2017–2019 (Thousand Procedures)
Table 77 North America: Breast Lesion Localization Methods Market,By Country, 2020–2025 (Thousand Procedures)
Table 78 North America: Breast Lesion Localization Methods Market,By Type, 2017–2019 (Thousand Procedures)
Table 79 North America: Breast Lesion Localization Methods Market, By Type, 2020–2025 (Thousand Procedures)
Table 80 North America: Radioisotope Localization Methods Market,By Type, 2017–2019 (Thousand Procedures)
Table 81 North America: Radioisotope Localization Methods Market,By Type, 2020–2025 (Thousand Procedures)
Table 82 North America: Breast Lesion Localization Methods Market,By Usage, 2017–2019 (Thousand Procedures)
Table 83 North America: Breast Lesion Localization Methods Market,By Usage, 2020–2025 (Thousand Procedures)
Table 84 North America: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type, 2017–2019 (Thousand Procedures)
Table 85 North America: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type,2020–2025 (Thousand Procedures)
Table 86 North America: Breast Lesion Localization Methods Market,By Type, 2017–2019 (USD Million)
Table 87 North America: Breast Lesion Localization Methods Market,By Type, 2020–2025 (USD Million)
           9.4.2 Us
                    9.4.2.1 Us To Dominate The North American Breast Lesion Localization Market
Table 88 Us: Breast Lesion Localization Methods Market, By Type,2017–2019 (Thousand Procedures)
Table 89 Us: Breast Lesion Localization Methods Market, By Type,2020–2025 (Thousand Procedures)
Table 90 Us: Radioisotope Localization Methods Market, By Type,2017–2019 (Thousand Procedures)
Table 91 Us: Radioisotope Localization Methods Market, By Type, 2020–2025 (Thousand Procedures)
Table 92 Us: Breast Lesion Localization Methods Market, By Usage,2017–2019 (Thousand Procedures)
Table 93 Us: Breast Lesion Localization Methods Market, By Usage,2020–2025 (Thousand Procedures)
Table 94 Us: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type, 2017–2019 (Thousand Procedures)
Table 95 Us: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type, 2020–2025 (Thousand Procedures)
Table 96 Us: Breast Lesion Localization Methods Market, By Type,2017–2019 (USD Million)
Table 97 Us: Breast Lesion Localization Methods Market, By Type,2020–2025 (USD Million)
           9.4.3 Canada
                    9.4.3.1 Increasing Incidence Of Breast Cancer And Government Initiatives For Breast Cancer Awareness To Drive Market Growth In Canada
Table 98 Canada: Breast Lesion Localization Methods Market, By Type, 2017–2019 (Thousand Procedures)
Table 99 Canada: Breast Lesion Localization Methods Market, By Type, 2020–2025 (Thousand Procedures)
Table 100 Canada: Radioisotope Localization Methods Market, By Type, 2017–2019 (Thousand Procedures)
Table 101 Canada: Radioisotope Localization Methods Market, By Type,2020–2025 (Thousand Procedures)
Table 102 Canada: Breast Lesion Localization Methods Market, By Usage, 2017–2019 (Thousand Procedures)
Table 103 Canada: Breast Lesion Localization Methods Market, By Usage, 2020–2025 (Thousand Procedures)
Table 104 Canada: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type, 2017–2019 (Thousand Procedures)
Table 105 Canada: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type, 2020–2025 (Thousand Procedures)
Table 106 Canada: Breast Lesion Localization Methods Market, By Type, 2017–2019 (USD Million)
Table 107 Canada: Breast Lesion Localization Methods Market, By Type, 2020–2025 (USD Million)
    9.5 Rest Of The World
           9.5.1 Covid-19 Impact On The Breast Lesion Localization Methods Market In The Rest Of The World
Table 108 Row: Breast Lesion Localization Methods Market, By Type,2017–2019 (Thousand Procedures)
Table 109 Row: Breast Lesion Localization Methods Market, By Type, 2020–2025 (Thousand Procedures)
Table 110 Row: Radioisotope Localization Methods Market, By Type,2017- 2019 (Thousand Procedures)
Table 111 Row: Radioisotope Localization Methods Market, By Type,2020–2025 (Thousand Procedures)
Table 112 Row: Breast Lesion Localization Methods Market, By Usage,2017–2019 (Thousand Procedures)
Table 113 Row: Breast Lesion Localization Methods Market, By Usage, 2020–2025 (Thousand Procedures)
Table 114 Row: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type,2017–2019 (Thousand Procedures)
Table 115 Row: Breast Lesion Localization Methods Market For Sentinel Lymph Node Identification, By Surgery Type,2020–2025 (Thousand Procedures)
Table 116 Row: Breast Lesion Localization Methods Market, By Type,2017–2019 (USD Million)
Table 117 Row: Breast Lesion Localization Methods Market, By Type, 2020–2025 (USD Million)

10 Competitive Landscape (Page No. - 109)
     10.1 Introduction
Figure 23 Key Developments In The Breast Lesion Localization Methods Market
     10.2 Competitive Leadership Mapping (Overall Market)
     10.3 Vendor Inclusion Criteria
     10.4 Vendor Dive
             10.4.1 Visionary Leaders
             10.4.2 Innovators
             10.4.3 Dynamic Differentiators
             10.4.4 Emerging Companies
Figure 24 Vendor Dive: Evaluation Overview
     10.5 Geographical Assessment Of The Major Players In The Breast Lesion Localization Methods Market
     10.6 Competitive Assessment Of R&D Expenditure
Figure 25 R&D Expenditure Of Key Players, 2018 Vs. 2019 (USD Million)
     10.7 Market Share Analysis
             10.7.1 Market Share Analysis: Global Breast Lesion Localization Methods Market
Figure 26 Global Breast Lesion Localization Methods Market Share,By Key Player, 2019
     10.8 Competitive Scenario
Table 118 Product Launches
Table 119 Acquisitions
Table 120 Agreements And Partnerships
     10.9 Breast Lesion Localization Methods: Comparative Analysis
     10.1 Breast Lesion Localization Methods: Comparative Analysis
Figure 27 Comparative Analysis: Detection Rate, Success Rate, And Re-Excision Rate
     10.11 Breast Lesion Localization Methods: Selection Criteria Evaluation
Figure 28 Selection Criteria Evaluation
     10.12 Qualitative Assessment Of Replacement Trends
Figure 29 Replacement Trends

11 Company Profiles (Page No. - 119)
(Business Overview, Products Offered, Recent Developments, Mnm View)*
     11.1 Hologic, Inc.
Figure 30 Hologic, Inc.: Company Snapshot
     11.2 Becton, Dickinson And Company
Figure 31 Becton, Dickinson And Company: Company Snapshot
     11.3 Cianna Medical, Inc.
Figure 32 Merit Medical Systems, Inc.: Company Snapshot
     11.4 Leica Biosystems
Figure 33 Danaher: Company Snapshot (2019)
     11.5 Argon Medical Devices, Inc.
     11.6 Laurane Medical
     11.7 Endomagnetics Limited
     11.8 Health Beacons, Inc.
     11.9 Intra-Medical Imaging
     11.1 Isoaid
     11.11 Somatex Medical Technologies
     11.12 Surgiceye Gmbh
     11.13 Ranfac Corporation
     11.14 Mermaid Medical Group
     11.15 Izi Medical
     11.16 Matek Medical Inc.
     11.17 Tsunami Medical
     11.18 Bpb Medica
     11.19 Sirius Medical Bv
     11.2 Molli Surgical Inc.

*Business Overview, Products Offered, Recent Developments, Mnm View Might Not Be Captured In Case Of Unlisted Companies.


12 Adjacent/Related Market – Breast Imaging Market (Page No. - 144)
     12.1 Introduction
     12.2 Breast Imaging Market
             12.2.1 Market Definition
             12.2.2 Limitations
             12.2.3 Market Overview
     12.3 Breast Imaging Market, By Region
Table 121 Breast Imaging Market, By Region, 2016–2023 (USD Million)
     12.4 Breast Imaging Market, By Technology
Table 122 Breast Imaging Market, By Technology, 2016–2023 (USD Million)
             12.4.1 Ionizing Breast Imaging Technologies Market
Table 123 Ionizing Breast Imaging Technologies Market, By Type, 2016–2023 (USD Million)
Table 124 Ionizing Breast Imaging Technologies Market, By Region, 2016–2023 (USD Million)
             12.4.2 Mammography
Table 125 Mammography Market, By Type, 2016–2023 (USD Million)
Table 126 Mammography Market, By Region, 2016–2023 (USD Million)
             12.4.3 Positron Emission Tomography-Computed Tomography (Pet-Ct)
                        12.4.3.1 Combined Scans From Pet And Ct Provide A More Accurate Diagnosis As Compared To The Individual Scans Performed
Table 127 Positron Emission Tomography-Computed Tomography Market,By Region, 2016–2023 (USD Million)
             12.4.4 Molecular Breast Imaging
                        12.4.4.1 Mbi Technique Is Simple, Fast, And Highly Sensitive And Can Be Used For Patients Who Are Claustrophobic Or Allergic To Gadolinium
Table 128 Molecular Breast Imaging Market, By Region,2016–2023 (USD Million)
             12.4.5 Positron Emission Mammography
                        12.4.5.1 Pem Involves Radiation Exposure Throughout The Body, Which Increases The Risk Of Cancer—A Major Disadvantage Associated With This Technique
Table 129 Positron Emission Mammography Market, By Region,2016–2023 (USD Million)
     12.5 Non-Ionizing Breast Imaging Technologies
Table 130 Non-Ionizing Breast Imaging Technologies Market, By Type,2016–2023 (USD Million)
Table 131 Non-Ionizing Breast Imaging Technologies Market, By Region, 2016–2023 (USD Million)
             12.5.1 Breast Ultrasound
                        12.5.1.1 Lower Cost, Increasing Awareness, And Easy Availability Of Ultrasound Devices For Breast Imaging Are Driving The Growth Of This Market
Table 132 Breast Ultrasound Market, By Region, 2016–2023 (USD Million)
             12.5.2 Breast Mri
                        12.5.2.1 Technological Advancements In Breast Mri And The Rising Demand For Technologies That Involve Minimal Use Of Radiation Are The Key Factors Driving The Growth Of This Market
Table 133 Breast Mri Market, By Region, 2016–2023 (USD Million)
             12.5.3 Automated Whole-Breast Ultrasound
                        12.5.3.1 Awbu Helps Spot Tiny Cancers In The Mammogram Of Fatty Breasts
Table 134 Automated Whole-Breast Ultrasound Market, By Region,2016–2023 (USD Million)
             12.5.4 Breast Thermography
                        12.5.4.1 This Technique Is Not Effective When Used As A Standalone Test For Breast Cancer Screening
Table 135 Breast Thermography Market, By Region, 2016–2023 (USD Million)
     12.6 Other Breast Imaging Technologies
             12.6.1 Optical Imaging
             12.6.2 Cone-Beam Computed Tomography
             12.6.3 Electric Impedance Tomography
Table 136 Breast Imaging Market For Other Technologies, By Region, 2016–2023 (USD Million)

13 Appendix (Page No. - 157)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details

This study involved four major activities in estimating the current market size for breast lesion localization method. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the number of breast lesion localization procedures and the value market. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Factors such as the global breast cancer population, percentage splits of palpable and non-palpable breast lesions, early and late-stage diagnosis, the number of breast cancer surgeries, and the cost of localization devices in various regions were studied through primary and secondary research to arrive at the global breast lesion localization methods value market (USD million) and volume market (million procedures). Secondary research included the study of the annual and financial reports of top market players, presentations, websites, and press releases of top players, news articles, journals; and paid databases, white papers, medical journals, certified publications, articles from recognized authors, directories, and databases such as Centers for Disease Control and Prevention (CDC), National Breast and Cervical Cancer Early Detection Program (NBCCEDP), World Health Organization (WHO), Organization for Economic Co-operation and Development (OECD), National Center for Biotechnology Information (NCBI), GLOBOCAN, International Agency for Research on Cancer, American College of Radiology (ACR), American Cancer Society (ACS), and European Institute of Oncology (IEO).

Primary research included extensive interviews with key opinion leaders such as CEOs, vice presidents, directors, marketing executives, and related key executives from various companies. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Primary Research

The breast lesion localization methods market comprises several stakeholders such as raw material suppliers, manufacturers of breast lesion localization devices, and regulatory organizations in the supply chain. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The primary interviewees from the demand side include professionals such as medical oncologists, medical directors and breast surgeons from hospitals, breast imaging medical centers, cancer research centers and institutes, medical schools and universities, clinical research organizations, and physicians in diagnostic centers. The primary sources from the supply side include key opinion leaders, distributors, and breast lesion localization device manufacturers.

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total size of the breast lesion localization methods market (in terms of value and volume). These approaches were also used extensively to estimate the size of various subsegments in the market. After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides of the breast lesion localization methods industry.

Breast Lesion Localization Methods Market

A detailed market estimation approach was followed to estimate and validate the size of the breast lesion localization methods market and other dependent submarkets.

Demand-side Approaches

In this report, a demand-side approach has been considered to arrive at the size of the breast lesion localization methods market. The first approach takes into account the global number of breast cancer patients and the second approach considers the number of breast cancer procedures performed in the US in a year.

Breast Lesion Localization Methods Market

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the breast lesion localization methods market on the basis of type, usage, and region.
  • To provide detailed information on the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.
  • To forecast the market size of segments with respect to North America, Europe, Asia Pacific and the Rest of the World (RoW).
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies.
  • To track and analyze competitive developments (such as acquisitions, product launches, partnerships, and agreements) in the breast lesion localization methods market.
  • To evaluate the different parameters considered for the selection of breast lesion localization.
  • To study end-user preferences for different breast lesion localization methods and the replacement trend and buying behavior of end users.

Available Customizations

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Regional Analysis

  • Further breakdown of the European market into Germany, France, UK, Italy, Spain, and the Rest of Europe (RoE)
  • Further breakdown of the Asia Pacific market into China, India, Japan, South Korea, Australia, and others
COVID-19

Get in-depth analysis of the COVID-19 impact on the Breast Lesion Localization Methods Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Breast Lesion Localization Methods Market

Request For Special Pricing
Report Code
MD 4236
Published ON
Jul, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Breast Lesion Localization Methods Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home